Breaking News

Theorem Names Business Development VP

March 27, 2013

Davis brings 15 years of management experience

Sara Davis has been appointed vice president of global business development at Theorem Clinical Research. Ms. Davis has more than 15 years of sales and management experience and a proven track record leading business development teams. She will be responsible for driving strategic growth plans for Theorem globally.
Ms. Davis began her career as an account executive with PRA International. She has held positions of increasing responsibility in both the biopharma and pharmaceutical industries.
“Sara’s depth of experience spans a variety of market segments from short-term tactical deals to large, multiyear, multimillion-dollar strategic partnerships,” said Dr. John Potthoff, Theorem president and chief executive officer. “We are just entering what we see as a long period of growth and Sara is ideal to help us manage the road up.”

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016